View Older Stories View More Recent Stories

Feb 14, 2022 10:31AM Form SC 13G/A MADRIGAL PHARMACEUTICALS Filed by: HealthCor Management, L.P.
Feb 14, 2022 10:30AM Form SC 13G/A Aurinia Pharmaceuticals Filed by: HealthCor Management, L.P.
Feb 14, 2022 10:30AM Form SC 13G/A ARYA Sciences Acquisitio Filed by: HealthCor Management, L.P.
Jan 26, 2022 05:00AM Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
Jan 4, 2022 04:25PM Form 4 CareView Communications For: Dec 31 Filed by: HealthCor Partners LP
Jan 4, 2022 04:01PM Form SC 13D/A CareView Communications Filed by: HealthCor Management, L.P.
Jan 4, 2022 06:21AM eureKARE participates in DNA Script’s $200 Million Series C Financing
Jan 4, 2022 06:21AM eureKARE participates in DNA Script’s $200 Million Series C Financing
Jan 4, 2022 06:00AM DNA Script Closes $200 Million Series C Financing with Completion of Second Tranche
Dec 31, 2021 09:08AM HealthCorps Announces Pedram Salimpour, MD, MPH as Board Member
Dec 27, 2021 09:13AM Form SEC STAFF LETTER HealthCor Catalio Acquis
Dec 27, 2021 09:13AM Form SEC STAFF LETTER HealthCor Catalio Acquis
Dec 22, 2021 12:44PM Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker "HYPR" on the Nasdaq Global Market
Dec 22, 2021 11:22AM Form 8-K HealthCor Catalio Acquis For: Dec 21
Dec 20, 2021 05:14PM Form S-4MEF HealthCor Catalio Acquis
Dec 16, 2021 08:09AM Form 425 HealthCor Catalio Acquis Filed by: HealthCor Catalio Acquisition Corp.
Dec 16, 2021 08:00AM Hyperfine and the Brain Tumor Foundation Launch National Partnership to Increase Access to Early Brain Tumor Detection
Dec 15, 2021 04:29PM Venture Investors Health Fund announces that Shelly Lanning has joined the firm as a Venture Partner
Dec 15, 2021 09:18AM Form 425 HealthCor Catalio Acquis Filed by: HealthCor Catalio Acquisition Corp.
Dec 15, 2021 08:30AM HealthCor Catalio Acquisition Corp. Reminds Shareholders to Vote in Favor of the Business Combination with Hyperfine, Inc. and Liminal Sciences, Inc.
Dec 13, 2021 08:06AM Form 425 HealthCor Catalio Acquis Filed by: HealthCor Catalio Acquisition Corp.
Dec 13, 2021 08:00AM Hyperfine Appoints New Board of Directors
Dec 13, 2021 06:01AM Form 8-K HealthCor Catalio Acquis For: Dec 10
Dec 13, 2021 06:01AM Form 425 HealthCor Catalio Acquis Filed by: HealthCor Catalio Acquisition Corp.
Dec 9, 2021 08:11AM Form 425 HealthCor Catalio Acquis Filed by: HealthCor Catalio Acquisition Corp.
Dec 9, 2021 08:00AM Hyperfine Announces Expansion into Canadian Market with Medical Device License Issued by Health Canada
Dec 8, 2021 04:16PM Form 425 HealthCor Catalio Acquis Filed by: HealthCor Catalio Acquisition Corp.
Dec 7, 2021 09:26AM Form 425 HealthCor Catalio Acquis Filed by: HealthCor Catalio Acquisition Corp.
Dec 7, 2021 08:00AM Hyperfine Partners With Madonna's Charitable Organization, Raising Malawi, to Increase Access to High Quality Healthcare for Children
Nov 29, 2021 08:36AM Form 425 HealthCor Catalio Acquis Filed by: HealthCor Catalio Acquisition Corp.
Nov 29, 2021 08:12AM Form 425 HealthCor Catalio Acquis Filed by: HealthCor Catalio Acquisition Corp.
Nov 29, 2021 08:00AM Hyperfine Receives FDA Clearance for Deep Learning Portable MRI, Defining the Future of Life-Saving Diagnostics
Nov 29, 2021 07:30AM Hyperfine, Liminal Sciences, and HealthCor Catalio Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination
Nov 29, 2021 06:02AM Form EFFECT HealthCor Catalio Acquis
Nov 26, 2021 05:02PM Form 424B3 HealthCor Catalio Acquis
Nov 19, 2021 05:23PM Form S-4/A HealthCor Catalio Acquis
Nov 18, 2021 05:10PM Form 10-Q HealthCor Catalio Acquis For: Sep 30
Nov 18, 2021 05:04PM Form 8-K HealthCor Catalio Acquis For: Nov 18
Nov 15, 2021 05:21PM Form NT 10-Q HealthCor Catalio Acquis For: Sep 30
Nov 15, 2021 01:17PM Form 13F-HR HealthCor Management, For: Sep 30
Nov 11, 2021 08:00AM Acrivon Therapeutics Closes Oversubscribed $100 Million Series B Financing to Advance its Innovative Precision Proteomics Platform and Clinical Oncology Pipeline
Nov 11, 2021 08:00AM Acrivon Therapeutics Closes Oversubscribed $100 Million Series B Financing to Advance its Innovative Precision Proteomics Platform and Clinical Oncology Pipeline
Nov 8, 2021 04:18PM Form S-4/A HealthCor Catalio Acquis
Nov 2, 2021 09:39AM Form 425 HealthCor Catalio Acquis Filed by: HealthCor Catalio Acquisition Corp.
Nov 2, 2021 08:00AM Hyperfine Announces Receipt of Additional $3.3 Million Grant to Improve Access to Neonatal and Pediatric Brain Imaging in Low-Resource Settings Globally
Oct 28, 2021 04:39PM Form 425 HealthCor Catalio Acquis Filed by: HealthCor Catalio Acquisition Corp.
Oct 28, 2021 04:10PM Hyperfine Appoints Scott White as Chief Commercial Officer
Oct 19, 2021 06:03AM Form 425 HealthCor Catalio Acquis Filed by: HealthCor Catalio Acquisition Corp.
Oct 14, 2021 04:25PM Form 425 HealthCor Catalio Acquis Filed by: HealthCor Catalio Acquisition Corp.
Oct 14, 2021 04:10PM Hyperfine Announces Formation Of Medical Advisory Board
View More Recent Stories View Older Stories